Not Cleared Direct

DEN230006 - esolution (FDA 510(k) Clearance)

Sep 2023
Decision
225d
Days
Class 2
Risk

DEN230006 is an FDA 510(k) submission for the esolution. This device is classified as a Esophageal Protection Device For Use In Percutaneous Cardiac Catheter Ablation Procedures, Mechanical Deviation (Class II - Special Controls, product code QXU).

Submitted by S4 Medical Corp. (Chagrin Falls, US). The FDA issued a Not Cleared (DENG) decision on September 6, 2023.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.5710. This Device Is Placed In The Lumen Of The Esophagus To Reduce The Likelihood Of Esophageal Injury Or A Specific Adverse Event During Cardiac Ablation Procedures. The Device Uses Mechanical Means To Deviate The Esophagus Away From The Source Of Ablation Energy.

Submission Details

510(k) Number DEN230006 FDA.gov
FDA Decision Not Cleared Not Substantially Equivalent (DENG)
Date Received January 24, 2023
Decision Date September 06, 2023
Days to Decision 225 days
Submission Type Direct
Review Panel Cardiovascular (CV)
Summary -

Device Classification

Product Code QXU - Esophageal Protection Device For Use In Percutaneous Cardiac Catheter Ablation Procedures, Mechanical Deviation
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.5710
Definition This Device Is Placed In The Lumen Of The Esophagus To Reduce The Likelihood Of Esophageal Injury Or A Specific Adverse Event During Cardiac Ablation Procedures. The Device Uses Mechanical Means To Deviate The Esophagus Away From The Source Of Ablation Energy